Showing results (61-70 of 132) with videos related to

Sort By:
Pageof 14
Cancer Medicine|May 7, 2020
Radiation pneumonitis in lung cancer patients treated with chemoradiation plus durvalumabNarek Shaverdian, Maria Thor, Annemarie F Shepherd, et al.
Practical Radiation Oncology|October 17, 2020
Clinical and Dosimetric Predictors of Radiation Pneumonitis in Patients With Non-Small Cell Lung Cancer Undergoing Postoperative Radiation TherapyAnnemarie F Shepherd, Michelle Iocolano, Jonathan Leeman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 12, 2011
Molecular characteristics predict clinical outcomes: prospective trial correlating response to the EGFR tyrosine kinase inhibitor gefitinib with the presence of sensitizing mutations in the tyrosine binding domain of the EGFR geneNaiyer A Rizvi, Valerie Rusch, William Pao, et al.
The Journal of Thoracic and Cardiovascular Surgery|November 13, 2018
Outcomes after neoadjuvant or adjuvant chemotherapy for cT2-4N0-1 non-small cell lung cancer: A propensity-matched analysisWhitney S Brandt, Wanpu Yan, Jian Zhou, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 4, 2020
Clinical outcomes, local-regional control and the role for metastasis-directed therapies in stage III non-small cell lung cancers treated with chemoradiation and durvalumabMichael Offin, Narek Shaverdian, Andreas Rimner, et al.
Cancer|September 9, 2025
Real-world outcomes of neoadjuvant chemoimmunotherapy in patients with nonsmall cell lung cancer: Predictors of surgery, pathologic complete response, and event-free survivalAlissa J Cooper, Edoardo Garbo, Andrea Arfe, et al.
Cancer Discovery|August 21, 2020
Prognostic and Predictive Impact of Circulating Tumor DNA in Patients with Advanced Cancers Treated with Immune Checkpoint BlockadeQu Zhang, Jia Luo, Song Wu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 25, 2017
Adjuvant Systemic Therapy and Adjuvant Radiation Therapy for Stage I to IIIA Completely Resected Non-Small-Cell Lung Cancers: American Society of Clinical Oncology/Cancer Care Ontario Clinical Practice Guideline UpdateMark G Kris, Laurie E Gaspar, Jamie E Chaft, et al.
Physics and Imaging in Radiation Oncology|October 15, 2025
Prospective validation of a pretreatment 18F-FDG PET/CT and mean lung dose model for early radiation pneumonitisMaria Thor, Aditya Apte, Milan Grkovski, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 5, 2023
Brief Report: Safety and Antitumor Activity of Durvalumab Plus Tremelimumab in Programmed Cell Death-(Ligand)1-Monotherapy Pretreated, Advanced NSCLC: Results From a Phase 1b Clinical TrialEdward B Garon, Alexander I Spira, Sarah B Goldberg, et al.
Pageof 14